These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Anti-hepatitis C virus antibodies and hepatitis C virus viraemia in haemodialysis patients. Picciotto A; Varagona G; Gurreri G; Fiorini F; Sofia A; Coviello DA; Bonanni P; Icardi GC; Valle F; Celle G Nephrol Dial Transplant; 1993; 8(10):1115-7. PubMed ID: 8272226 [TBL] [Abstract][Full Text] [Related]
5. Prevalence and role of hepatitis C viraemia in haemodialysis patients in Japan. Hayashi J; Nakashima K; Yoshimura E; Kishihara Y; Ohmiya M; Hirata M; Kashiwagi S J Infect; 1994 May; 28(3):271-7. PubMed ID: 7522260 [TBL] [Abstract][Full Text] [Related]
6. A 3-year follow-up of HCV-RNA viraemia in haemodialysis patients. Galán F; Pérez-Gracia MT; Lozano A; Benavides B; Fernandez-Ruíz E; Rodríguez-Iglesias MA Nephrol Dial Transplant; 1998 May; 13(5):1211-4. PubMed ID: 9623556 [TBL] [Abstract][Full Text] [Related]
7. Patterns of viraemia in haemodialysis patients with hepatitis C. Dzekova-Vidimliski P; Asani A; Selim G; Gelev S; Polenakovic M; Sikole A Prilozi; 2008 Dec; 29(2):201-11. PubMed ID: 19259047 [TBL] [Abstract][Full Text] [Related]
8. Decreased prevalence and incidence of HCV markers in haemodialysis units: a multicentric French survey. Sauné K; Kamar N; Miédougé M; Weclawiak H; Dubois M; Izopet J; Rostaing L Nephrol Dial Transplant; 2011 Jul; 26(7):2309-16. PubMed ID: 21097646 [TBL] [Abstract][Full Text] [Related]
9. Different kinetics of HBV and HCV during haemodialysis and absence of seronegative viral hepatitis in patients with end-stage renal disease. Mederacke I; Meier M; Lüth JB; Schmidt-Gürtler H; Raupach R; Horn-Wichmann R; Wursthorn K; Potthoff A; Colucci G; Manns MP; Wedemeyer H; Tillmann HL Nephrol Dial Transplant; 2011 Aug; 26(8):2648-56. PubMed ID: 21273235 [TBL] [Abstract][Full Text] [Related]
10. Detection of anti-hepatitis C-virus antibodies and hepatitis C-virus RNA in Lebanese hemodialysis patients. Abdelnour GE; Matar GM; Sharara HM; Abdelnoor AM Eur J Epidemiol; 1997 Dec; 13(8):863-7. PubMed ID: 9476813 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis C infection in dialysis patients in Israel. Weinstein T; Tur-Kaspa R; Chagnac A; Korzets A; Ori Y; Zevin D; Herman M; Gafter U Isr Med Assoc J; 2001 Mar; 3(3):174-7. PubMed ID: 11303373 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of anti-HCV and HCV viremia in hemodialysis patients in Taiwan. Sheu JC; Lee SH; Wang JT; Shih LN; Wang TH; Chen DS J Med Virol; 1992 Jun; 37(2):108-12. PubMed ID: 1378482 [TBL] [Abstract][Full Text] [Related]
13. High prevalence of hepatitis C virus (HCV) RNA in dialysis patients: failure of commercially available antibody tests to identify a significant number of patients with HCV infection. Copenhagen Dialysis HCV Study Group. Bukh J; Wantzin P; Krogsgaard K; Knudsen F; Purcell RH; Miller RH J Infect Dis; 1993 Dec; 168(6):1343-8. PubMed ID: 7504031 [TBL] [Abstract][Full Text] [Related]
14. Incidence and risk factors of hepatitis C virus infection in a haemodialysis unit. Forns X; Fernández-Llama P; Pons M; Costa J; Ampurdanés S; López-Labrador FX; Olmedo E; López-Pedret J; Darnell A; Revert L; Sánchez-Tapias JM; Rodés J Nephrol Dial Transplant; 1997 Apr; 12(4):736-40. PubMed ID: 9141004 [TBL] [Abstract][Full Text] [Related]
15. Prevalence and risk factors of hepatitis C virus infection in haemodialysis patients: a multicentre study in 2796 patients. Hinrichsen H; Leimenstoll G; Stegen G; Schrader H; Fölsch UR; Schmidt WE; Gut; 2002 Sep; 51(3):429-33. PubMed ID: 12171969 [TBL] [Abstract][Full Text] [Related]
16. [Detection of HCV RNA in anti-HCV positive patients with chronic hepatic porphyria]. Malina L; Zdárský E; Havlícková M; Stránský J Cas Lek Cesk; 1996 Jul; 135(13):427-9. PubMed ID: 8925541 [TBL] [Abstract][Full Text] [Related]
17. De novo HCV infection among dialysis patients: a prospective study by HCV core antigen ELISA assay. Fabrizi F; de Vecchi AF; Como G; Lunghi G; Martin P Aliment Pharmacol Ther; 2005 Apr; 21(7):861-9. PubMed ID: 15801921 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of a total hepatitis C virus (HCV) core antigen assay for the detection of antigenaemia in anti-HCV positive individuals. Valcavi P; Medici MC; Casula F; Arcangeletti MC; De Conto F; Pinardi F; Calderaro A; Chezzi C; Dettori G J Med Virol; 2004 Jul; 73(3):397-403. PubMed ID: 15170635 [TBL] [Abstract][Full Text] [Related]
19. [Investigation of the correlation between anti-HCV levels (S/Co) with HCV-RNA in the diagnosis of hepatitis C virus (HCV) infection]. Şanlıdağ T; Akçalı S; Ecemiş T; Süer K; Erbay Dündar P; Arıkan A; Güvenir M; Güler E Mikrobiyol Bul; 2016 Jul; 50(3):508-10. PubMed ID: 27525408 [TBL] [Abstract][Full Text] [Related]
20. Screening haemodialysis patients for hepatitis C in Vietnam: The inconsistency between common hepatitis C virus serological and virological tests. Duong MC; McLaws ML J Viral Hepat; 2019 Jan; 26(1):25-29. PubMed ID: 30187621 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]